# Filing Detail

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001437749-16-043833
Filing Date
2016-12-28
Accepted
2016-12-28 10:41:32
Documents
100

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM S-1/A | atrn20161212_s1a.htm | S-1/A | 2470856
2 | EXHIBIT 23.1 | ex23-1.htm | EX-23.1 | 4082
3 | EXHIBIT 23.2 | ex23-2.htm | EX-23.2 | 6112
10 |  | prota.jpg | GRAPHIC | 27080
11 |  | schulman.jpg | GRAPHIC | 376408
| Complete submission text file | 0001437749-16-043833.txt |  | 10455682

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
4 | EXHIBIT 101.INS | atrn-20160930.xml | EX-101.INS | 1403182
5 | EXHIBIT 101.SCH | atrn-20160930.xsd | EX-101.SCH | 91195
6 | EXHIBIT 101.CAL | atrn-20160930_cal.xml | EX-101.CAL | 56648
7 | EXHIBIT 101.DEF | atrn-20160930_def.xml | EX-101.DEF | 815437
8 | EXHIBIT 101.LAB | atrn-20160930_lab.xml | EX-101.LAB | 430166
9 | EXHIBIT 101.PRE | atrn-20160930_pre.xml | EX-101.PRE | 826572

Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-213671 | Film No.: 162071634
SIC: 7389 Services-Business Services, NEC